The study also provided potential strategies to treat metastatic cancer, as both DMBT1 targeting with a neutralizing antibody and MUC1 inhibition by GO203 effectively suppresses NET formation and liver metastasis. Here, DMBT1 is linked to metastatic malignant neoplasm.